文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Obesity and Liver Cancer.

作者信息

Aleksandrova Krasimira, Stelmach-Mardas Marta, Schlesinger Sabrina

机构信息

Nutrition, Immunity and Metabolism Start-up Lab, Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

出版信息

Recent Results Cancer Res. 2016;208:177-198. doi: 10.1007/978-3-319-42542-9_10.


DOI:10.1007/978-3-319-42542-9_10
PMID:27909908
Abstract

Obesity and related metabolic disorders have become globally prevalent posing a challenge for the chronically damaged liver and predisposing the development and progression of cancer. The rising phenomenon of "obesity epidemic" may provide means for understanding why liver cancer is one of the few malignancies with rising incidence in developed countries over the last decades. Non-alcoholic fatty liver disease associated with obesity, insulin resistance, and type 2 diabetes is an increasingly recognized trigger for liver cancer in Western populations characterized by low prevalence of established risk factors for liver cancer such as viral hepatitis and hepatotoxin exposure. Accumulating evidence has established an association between higher body mass index as an indicator of general obesity and higher risk of primary liver cancer. The associations are stronger in men, in patients with underlying liver disease and in white ethnic groups. Abdominal obesity, weight gain in adult life and metabolic factors related to visceral fat accumulation were also suggested as important risk factors for liver cancer; however, more studies are needed to evaluate these associations. The association of obesity and metabolic parameters with liver cancer survival remains controversial. It is unclear which exact mechanisms could provide links between obesity and liver cancer risk. Recent evidence has implicated several molecular pathways in obesity-associated liver cancer. These include insulin resistance leading to increased levels of insulin and insulin-like growth factors, chronic inflammation, adipose tissue remodeling, pro-inflammatory cytokine and adipokine secretion, and altered gut microbiota. These mechanisms coincide with inflammatory and metabolic processes occurring in non-alcoholic fatty liver disease predisposing cancer development and progression. In the context of the current evidence, better understanding of the role of obesity and related metabolic factors may help in improving current strategies for liver cancer prevention.

摘要

相似文献

[1]
Obesity and Liver Cancer.

Recent Results Cancer Res. 2016

[2]
Obesity-associated mechanisms of hepatocarcinogenesis.

Metabolism. 2014-2-5

[3]
Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.

Recent Results Cancer Res. 2016

[4]
Obesity and Endometrial Cancer.

Recent Results Cancer Res. 2016

[5]
Obesity and Ovarian Cancer.

Recent Results Cancer Res. 2016

[6]
Obesity and Breast Cancer.

Recent Results Cancer Res. 2016

[7]
Biological Mechanisms for the Effect of Obesity on Cancer Risk: Experimental Evidence.

Recent Results Cancer Res. 2016

[8]
Obesity and Prostate Cancer.

Recent Results Cancer Res. 2016

[9]
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.

World J Gastroenterol. 2015-4-14

[10]
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.

Gastroenterology. 2020-5

引用本文的文献

[1]
Liver cancer incidence in Saudi Arabia (2001-2020): decreasing trend.

BMC Cancer. 2025-8-8

[2]
Mechanisms underlying obesity-malignancy connection: a systematic narrative review.

J Physiol Biochem. 2025-5-23

[3]
Effect of Semaglutide on High-Fat-Diet-Induced Liver Cancer in Obese Mice.

J Proteome Res. 2024-2-2

[4]
RNA m6A methylation regulators in liver cancer.

Cancer Cell Int. 2024-1-2

[5]
The association of pericardial fat and peri-aortic fat with severity of nonalcoholic fatty liver disease.

Sci Rep. 2022-8-18

[6]
Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells.

BMC Cancer. 2022-3-24

[7]
Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition.

Nutrients. 2021-4-2

[8]
Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis.

Med Oncol. 2021-4-26

[9]
Dose-Response Association between Adiposity and Liver Cancer Incidence: A Prospective Cohort Study among Non-Smoking and Non-Alcohol-Drinking Chinese Women.

Cancer Epidemiol Biomarkers Prev. 2021-6

[10]
Transcriptome Analysis of Subcutaneous Adipose Tissue from Severely Obese Patients Highlights Deregulation Profiles in Coding and Non-Coding Oncogenes.

Int J Mol Sci. 2021-2-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索